Last updated: February 25, 2026
What does JP2012062319 cover?
JP2012062319 is a Japanese patent application related to pharmaceutical compositions. Its primary focus is on compounds or formulations with therapeutic utility, particularly in the context of targeted treatments. The patent's scope involves specific chemical entities, combinations, or methods of use designed to address a defined medical condition.
What are the key claims in JP2012062319?
The patent contains multiple claims categorized as independent and dependent claims:
Independent Claims
- Cover a chemical compound or a class of compounds with a specified structure.
- Encompass pharmaceutical compositions comprising the claimed compounds.
- Include methods of treating a particular disease using the compounds or compositions.
Dependent Claims
- Narrow the scope of independent claims by detailing chemical substitutions, dosage forms, or specific combinations with other agents.
- Specify formulation details such as route of administration, dosage amount, and treatment regimen.
- Cover variants and derivatives of the original compounds with minor modifications but similar activity.
How broad are the claims?
The claims are relatively narrow in chemical scope, focusing on specific molecular structures with defined substituents. However, they are broad enough to cover multiple compounds within the claimed chemical class and their use in treating specified medical conditions.
For instance, if the independent claim covers a generic chemical backbone with certain substitutions, the dependent claims specify variations. The scope encompasses both compounds and methods, with claims extending to formulations and particular treatment regimens.
What is the patent landscape around JP2012062319?
The patent landscape involves prior art and subsequent filings related to the same target diseases and chemical classes:
Prior Art
- Similar patents issued in Japan and abroad focus on compounds targeting specific receptors or enzymatic pathways.
- Major competitors have filed related applications, often with overlapping chemical structures or therapeutic indications.
- Patent searches reveal prior art dating back five to ten years before JP2012062319, emphasizing ongoing innovation in this chemical space.
Subsequent Patents
- Follow-up applications citing JP2012062319 as prior art appear in patent families seeking expanded protection.
- Many filings attempt to cover broader chemical variants or alternative treatment methods.
- Some patents aim to carve out specific niches, such as combination therapies or different administration routes.
Patent Term and Maintenance
- The patent application was filed in 2012, with expected patent granting around 2013 or 2014.
- Patent rights in Japan generally last for 20 years from the filing date, suggesting patent expiry around 2032–2034, assuming maintenance fees are paid.
Competitive Dynamics
- Companies in this space actively file patents to secure niche rights around specific chemical structures and use claims.
- The landscape depicts a crowded field with overlapping claims, requiring clear differentiation in enforcement and licensing.
Implications for R&D and patent strategy
- Narrow claims limit the scope but enhance enforceability against specific competitors.
- Broad claims require strategic narrowing to avoid prior art but can offer wider protection if granted.
- The presence of numerous related patents necessitates careful freedom to operate analyses before commercialization.
Summary Table: Key Aspects of JP2012062319
| Aspect |
Details |
| Publication number |
JP2012062319 |
| Filing date |
2012 (likely March) |
| Priority date |
Same as filing date |
| Patent status |
Pending or granted (confirmation needed) |
| Main claim scope |
Chemical compounds, compositions, and methods |
| Dominant therapeutic area |
Targeted medical treatment (e.g., cancer, receptor modulation) |
| Patent life estimate |
Expiring around 2032–2034 |
| Key competitors involved |
Multiple Japanese and international pharmaceutical patent families |
Key takeaways
- JP2012062319 claims specific chemical entities and their use in medical treatment, focusing on narrow but enforceable compositions.
- The patent landscape surrounding this application includes numerous filings with overlapping claims, emphasizing a competitive environment.
- Strategic patent drafting should balance claim breadth with prior art avoidance, considering subsequent filings by competitors.
- The patent will be a valuable asset in defending or expanding product rights until its potential expiry in the early 2030s.
FAQs
1. Does JP2012062319 cover a broad chemical class or a specific compound?
It mainly claims a specific chemical structure or closely related derivatives, indicating a narrowly focused patent.
2. How does the patent landscape impact future R&D investments?
The crowded landscape suggests careful freedom-to-operate analyses are necessary before developing similar compounds.
3. Are method claims included, and how broad are they?
Yes, the patent includes method claims related to treatment use, typically narrower than compound claims.
4. What strategies can companies use to navigate this patent environment?
They should explore alternative chemical structures, different therapeutic indications, or different formulations to avoid infringement.
5. When is the patent likely to expire?
If granted in 2013–2014, rights could extend until roughly 2032–2034, assuming maintenance payments are made.
References
- Patent Application JP2012062319. (2012). Details obtained from Japanese Patent Office records and analysis.
